tiprankstipranks
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
Holding GB:OBI?
Track your performance easily

Ondine Biomedical, Inc. (OBI) Financial Statements

7 Followers

Ondine Biomedical, Inc. Financial Overview

Ondine Biomedical, Inc.'s market cap is currently ―. The company's EPS TTM is p-0.037; its P/E ratio is -2.34; Ondine Biomedical, Inc. is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 20.93MC$ 30.36MC$ 575.00KC$ 626.00K
Total AssetsC$ 25.31MC$ 34.14MC$ 2.55MC$ 2.63M
Total DebtC$ 720.00KC$ 739.00KC$ 33.40MC$ 31.46M
Net DebtC$ -20.21MC$ -29.63MC$ 32.82MC$ 30.83M
Total LiabilitiesC$ 3.49MC$ 4.48MC$ 39.27MC$ 36.46M
Stockholders EquityC$ 21.82MC$ 29.66MC$ -36.70MC$ -33.81M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in CAD

Ondine Biomedical, Inc. Earnings and Revenue History

Ondine Biomedical, Inc. Debt to Assets

Ondine Biomedical, Inc. Cash Flow

Ondine Biomedical, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis